Bio Techne News Today

According to the report published by Allied Market Research, the Australia and New Zealand fetal bovine serum market was pegged at $20 million in 2020 and is estimated to hit $35 million by 2030, registering a CAGR of 5.2% from 2021 to 2030. The report provides an in-depth analysis of the top investment pockets, top...

Benchmark reaffirmed their buy rating on shares of Bio-Techne (NASDAQ:TECH – Free Report) in a report released on Thursday, Benzinga reports. The firm currently has a $95.00 target price on the biotechnology company’s stock. Other equities research analysts have also issued research reports about the stock. Royal Bank of Canada reduced their price objective on […]

Bio-Techne (NASDAQ:TECH – Get Free Report) had its target price hoisted by equities research analysts at Robert W. Baird from $73.00 to $81.00 in a note issued to investors on Thursday, Benzinga reports. The firm presently has an “outperform” rating on the biotechnology company’s stock. Robert W. Baird’s price objective would suggest a potential upside […]

Bio-Techne (NASDAQ:TECH – Get Free Report) issued its quarterly earnings data on Wednesday. The biotechnology company reported $0.48 EPS for the quarter, topping analysts’ consensus estimates of $0.45 by $0.03, Briefing.com reports. Bio-Techne had a net margin of 19.58% and a return on equity of 14.21%. The firm had revenue of $303.43 million for the […]

Bio-Techne (NASDAQ:TECH – Get Free Report)‘s stock had its “buy” rating reaffirmed by research analysts at Benchmark in a research note issued on Thursday, Benzinga reports. They presently have a $95.00 price target on the biotechnology company’s stock. Benchmark’s price target points to a potential upside of 27.86% from the company’s current price. TECH has […]

Bio-Techne Co. (NASDAQ:TECH – Get Free Report) announced a quarterly dividend on Wednesday, May 1st, Zacks reports. Investors of record on Monday, May 13th will be paid a dividend of 0.08 per share by the biotechnology company on Friday, May 24th. This represents a $0.32 annualized dividend and a dividend yield of 0.44%. The ex-dividend […]

Bio-Techne Co. (NASDAQ:TECH – Get Free Report) announced a quarterly dividend on Wednesday, May 1st, Zacks reports. Investors of record on Monday, May 13th will be given a dividend of 0.08 per share by the biotechnology company on Friday, May 24th. This represents a $0.32 annualized dividend and a yield of 0.44%. The ex-dividend date […]

Key Insights Using the 2 Stage Free Cash Flow to Equity, Bio-Techne fair value estimate is US$50.46 Bio-Techne is...

Zurcher Kantonalbank Zurich Cantonalbank increased its holdings in shares of Bio-Techne Co. (NASDAQ:TECH – Free Report) by 14.5% in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 28,038 shares of the biotechnology company’s stock after purchasing an additional 3,559 shares during the quarter. Zurcher […]

Linden Thomas Advisory Services LLC lifted its stake in shares of Bio-Techne Co. (NASDAQ:TECH – Free Report) by 3.3% during the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm owned 28,441 shares of the biotechnology company’s stock after purchasing an additional 899 shares during […]